The transaction positions KD Pharma Group as the largest omega-3 manufacturer in the world BIOGGO, TICINO, SWITZERLAND, October 1, 2024 /EINPresswire.com/ -- The KD ...
The transaction expands KD Pharma Group‘s lipids CDMO business and includes the MEG-3® fish oil omega-3 product portfolio and two associated production sites ...
KD Pharma Group successfully placed a senior secured bond with an issue volume of EUR 180 million and a maturity of 5 years BIOGGO, SWITZERLAND, October 2, 2024 ...
DSM-Firmenich plans to sell its omega-3 fish oil business, which has annual sales of about $185 million, to KD Pharma Group for an undisclosed sum. As part of the deal, DSM-Firmenich will get a 29% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results